Statistics for Ionis Pharmaceuticals (id:7340 IONS)

Valuation metrics

Market cap

5.59B

Enterprise value

4.83B

Trailing P/E (ttm)

-13.31

Forward P/E

-9.47

PEG ratio

-9.47

Price/Sales (ttm)

6.96

Price/Book (mrq)

8.43

Enterprise Value/Revenue

6.02

Enterprise Value/EBITDA

-14.37

Overview

Shares outstanding

157.90M

Float

156.63M

Shares short

10.74M

% Held by insiders

0.01%

% Held by institutions

1.06%

Average volume (10 days)

1.36M

Average volume (90 days)

Price summary

52-Week low

33.33

52-Week high

54.44

52-Week change

-46.20%

Beta

0.39

50-Day moving average

39.15

200-Day moving average

43.04

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-44.68%

Operating margin

-111.09%

Operational effectiveness

Return on assets

-7.25%

Return on equity

-73.38%

Income statement

Revenue (ttm)

5.50

Revenue per share (ttm)

5.50

Quarterly revenue growth (yoy)

Gross profit (ttm)

778.51M

EBITDA

-336,270,016.00

Net income to common (ttm)

-358,811,008.00

Diluted EPS (ttm)

-2.44

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

2.49B

Total cash per share (mrq)

15.78

Total debt (mrq)

1.99B

Total Debt/Equity (mrq)

301.12

Current ratio (mrq)

891.10%

Book value per share (mrq)

4.20

Cash flow

Cash flow statement

-351,943,008.00

Levered free cash flow (LFCF)

-171,627,744.00